Tenaya Therapeutics Inc.

NASDAQ: TNYA · Real-Time Price · USD
1.16
0.21 (22.51%)
At close: Aug 15, 2025, 3:59 PM
1.17
0.81%
After-hours: Aug 15, 2025, 07:56 PM EDT

Tenaya Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.32M 45.68M 95.27M 38.13M
Short-Term Investments
57.12M 58.96M 91.25M 213.17M
Long-Term Investments
n/a n/a 17.7M 547K
Other Long-Term Assets
4.82M 5.68M 4.79M 4.13M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a -19.95M n/a
Other Current Assets
842K 1.16M 7.23M 4.06M
Total Current Assets
67.38M 111.58M 193.75M 255.36M
Property-Plant & Equipment
47.75M 53.26M 62.7M 54.7M
Goodwill & Intangibles
n/a n/a n/a -3M
Total Long-Term Assets
52.56M 58.93M 85.19M 58.83M
Total Assets
119.94M 170.51M 278.94M 314.19M
Account Payables
5.16M 5.63M 9.58M 10.72M
Deferred Revenue
n/a n/a n/a 8.9M
Short-Term Debt
2.78M n/a 4.01M 1.99M
Other Current Liabilities
5.81M 9.27M 2.96M 1.83M
Total Current Liabilities
15.97M 22.73M 24.25M 21.77M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
281K 253K 228K 182K
Total Long-Term Liabilities
11.11M 8.36M 11.32M 13.89M
Total Liabilities
27.09M 31.09M 278.94M 35.66M
Total Debt
13.61M 12.42M 15.1M 13.71M
Common Stock
8K 7K 7K 4K
Retained Earnings
-514.41M -403.28M -279.2M -155.53M
Comprehensive Income
28K -106K -378K -141K
Shareholders Equity
92.85M 139.42M 243.38M 278.53M
Total Investments
57.12M 58.96M 108.96K 213.17M